Following NVIDIA's recent announcement of receiving U.S. government authorization to resume H20 AI chip exports to China, AMD has confirmed it is on track to restart shipments of its MI308 AI chips to the Chinese market.

On July 15, AMD officially stated that it had recently been notified by the U.S. government that its export license application for the MI308 is advancing to the review stage. "We plan to resume shipments once the license is approved," AMD noted.

Earlier in April 2025, the U.S. implemented new export controls targeting advanced AI chips, including NVIDIA's H20 and AMD's MI308, restricting sales to China, Hong Kong, Macau, and other D5 countries. AMD disclosed in its April 16 8-K filing that these controls would impact its MI308 products and that the company had initiated the licensing process, though approval was not guaranteed. At the time, AMD anticipated an $800 million loss due to affected inventory and customer orders.

As a result of these restrictions, AMD projected Q2 2025 revenue of approximately $7.4 billion, with a variance of $300 million. The company also forecasted a Non-GAAP gross margin of 43%, factoring in about $800 million in inventory and related charges linked to the export limitations. Excluding these charges, AMD's Non-GAAP gross margin would stand at around 54%.

In the Q1 earnings call, AMD CFO Jean Hu highlighted that the April export restrictions were expected to reduce FY2025 revenue by $1.5 billion. CEO Lisa Su further stated that most of the impact from U.S. export controls on China would be felt in Q2 and Q3 of 2025. However, Su remained optimistic, predicting that AI chip revenue within AMD's data center segment would achieve "strong double-digit growth" in 2025.

With the MI308 exports now anticipated to resume, AMD's overall revenue loss for FY2025 is expected to be significantly less than the previously estimated $1.5 billion.